Pacliaqualip 30 Injection contains Paclitaxel in a specialised liposomal or nanosomal formulation. It is an antineoplastic (chemotherapy) agent used to treat advanced malignancies including ovarian cancer, breast cancer, non-small cell lung cancer (NSCLC), and Kaposi's sarcoma.
Paclitaxel works by targeting and stabilizing microtubule structures within cancer cells, preventing cell division and inhibiting tumour proliferation and growth.
This medication is administered strictly under oncologist supervision as an intravenous infusion in a hospital or clinical setting. Dosing schedules and premedication protocols are tailored based on patient body surface area, cancer stage, and blood parameters.
Patients undergo regular blood tests, cardiac monitoring, and liver function checks during therapy. Inform your medical team immediately if you experience signs of infection, severe allergic reaction, or shortness of breath.

























































